Literature DB >> 6939885

Metabolism and pharmacokinetics of penicillamine in rats -- an overview.

F Planas-Bohne.   

Abstract

Penicillamine, a fairly stable mercaptoamino acid, undergoes virtually no metabolic degradation in mammals. The substance, especially the L-form, is taken up by most organs, in particular, by those with high collagen content. L-penicillamine shows more affinity for the mature collagen fraction than does D-penicillamine, which is distributed almost equally between the 2 immature fractions. Both enantiomers are bound to plasma proteins, especially to albumin, through S-S bridges. Penicillamine enhances renal copper excretion in normal, as well as in copper-loaded, man and animals. Results reported concerning other trace elements are contradictory.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6939885

Source DB:  PubMed          Journal:  J Rheumatol Suppl        ISSN: 0380-0903


  5 in total

1.  Genetic aspects of the polymodally distributed sulphoxidation of S-carboxymethyl-L-cysteine in man.

Authors:  S C Mitchell; R H Waring; C S Haley; J R Idle; R L Smith
Journal:  Br J Clin Pharmacol       Date:  1984-10       Impact factor: 4.335

Review 2.  Clinical pharmacokinetics of D-penicillamine.

Authors:  P Netter; B Bannwarth; P Péré; A Nicolas
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

Review 3.  Drug-induced nephrotoxicity. Aetiology, clinical features and management.

Authors:  A J Hoitsma; J F Wetzels; R A Koene
Journal:  Drug Saf       Date:  1991 Mar-Apr       Impact factor: 5.606

4.  A western blot approach to detection of human plasma protein conjugates derived from D-penicillamine.

Authors:  C A Laycock; M J Phelan; R C Bucknall; J W Coleman
Journal:  Ann Rheum Dis       Date:  1994-04       Impact factor: 19.103

5.  D-penicillamine metabolism in an in-vivo model of inflamed synovium.

Authors:  D A Joyce; M J Forrest; P M Brooks
Journal:  Agents Actions       Date:  1988-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.